Perceptive Advisors LLC Repligen Corp Transaction History

Perceptive Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$194.77 - $324.21 $25.8 Million - $43 Million	-132,500 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$165.87 - $220.95 $22 Million - $29.3 Million	132,500 New	132,500 $26.5 Million
Q1 2021 May 17, 2021	SELL	$180.37 - $226.26 $17.6 Million - $22.1 Million	-97,500 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$148.08 - $206.57 $14.4 Million - $20.1 Million	97,500 New	97,500 $18.7 Million
Q4 2017 Feb 14, 2018	SELL	$32.53 - $38.92 $2.84 Million - $3.4 Million	-87,400 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$36.98 - $46.06 $3.23 Million - $4.03 Million	87,400	87,400 $3.35 Million

486

54.3M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.91B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.